Laurence Rodriguez
Algemeen Directeur bij GENSIGHT BIOLOGICS S.A.
Profiel
Laurence Rodriguez is currently the Chief Executive Officer & Director at Gensight Biologics SA. Previously, she worked as the Head of Rare Diseases & Rare Blood Disorders at Genzyme Therapeutics Ltd.
Ms. Rodriguez completed her undergraduate and graduate degrees at Sciences Po.
Actieve functies van Laurence Rodriguez
| Bedrijven | Functie | Begin |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Algemeen Directeur | 21-12-2023 |
Eerdere bekende functies van Laurence Rodriguez
| Bedrijven | Functie | Einde |
|---|---|---|
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Opleiding van Laurence Rodriguez
| Sciences Po | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
